CSIRO begins testing Covid-19 vaccines as part of global effort

By Peter Roberts In an exciting development Australia’s CSIRO has begun testing potential vaccines against the Covid-19 coronavirus at its Australian Animal Health Laboratory (AAHL) facility in Geelong. Testing in the biosecure facility originally built to contain the world’s most harmful plant and animal diseases is part of a global effort led by the interational Coalition…

Drug companies should drop their patents and collaborate to fight coronavirus

As the coronavirus pandemic continues to claim victims around the world, the race is on to produce the right medicines to fight it. This includes developing a vaccine to stop people from falling ill in the first place, testing kits and drugs to treat those that fall ill with COVID-19.

Noxopharm investigates Covid-19 treatment

Drug developer Noxopharm is following up on indications that an experimental anti-cancer drug may be effective against the Covid-19 coronavirus. Melbourne’s Hudson Institute of Medical Research has identified anti-inflammatory properties of the experimental drug idronoxil, the active ingredient in the company’s anti-cancer drug candidate Veyonda. Pre-clinical models indicate the drug has the ability to treat…